---
author: Harvey Guo
created: 2023-10-12 11:34
modified: 2023-10-12 11:34
aliases: Untitled
share: true
---
# Statins
![[Pasted image 20231012113514.png]]
# Ezetimibe
Mechanism of action: selective inhibition of cholesterol reabsorption at the<span style="background:rgba(240, 200, 0, 0.2)"> brush border of enterocytes (cholesterol transporter NPC1L1)</span> → ↓↓ LDL, little effect on HDL (slight ↑) and triglycerides (slight ↓)
>[!Mnemonic] 
>Ezetim<span style="background:rgba(240, 200, 0, 0.2)">IB</span>e -- Intestinal brush border
# Fibrates
- Agents: bezafibrate, fenofibrate, and gemfibrozil
- Mechanism of action: <span style="background:rgba(240, 200, 0, 0.2)">activation of the peroxisome proliferator-activated receptor alpha (PPAR–α)</span> → ↑ lipoprotein lipase activity → <span style="background:rgba(240, 200, 0, 0.2)">more rapid degradation of LDL and triglycerides and induction of HDL synthesis</span> → ↓ LDL, ↑ HDL, ↓↓↓ triglyceride
- Adverse effects
	- Dyspepsia
	- Myopathy, especially in combination with statins 
	- <span style="background:rgba(240, 200, 0, 0.2)">[[Cholelithiasis]]: fibrates inhibit cholesterol 7α hydroxylase → decreased bile acid synthesis → supersaturation of bile with cholesterol (↑ cholesterol:bile acid ratio)</span>
	- ↑ LFTs (reversible)

![[Pasted image 20231012134711.png]]